On Tuesday, Feb. 4, 2020, President Donald Trump delivered the 2020 State of the Union Address (SOTU). The SOTU is an annual message delivered by the president to a joint session of Congress at the beginning of each year.
At this year’s SOTU, President Trump’s speech covered topics that have the potential to impact the employee benefits industry, including a strong economy with low unemployment, private health care, federal paid family leave and the potential for further prescription drug cost reform.
In the SOTU, President Trump highlighted that the country’s unemployment rate continues to decrease. According to the most recent data from the Bureau of Labor Statistics, the nationwide average unemployment rate is 3.5%. The unemployment rate reached a 50-year low in late 2019.
The labor market, which has been a tight market for the past few years, continues to demonstrate the effects of low unemployment and a strong economy. Employers will continue to feel the effects of a tight labor market, which includes difficulty hiring qualified candidates and retaining top talent.
President Trump offered support for the efficacy of employer-sponsored private health care for the majority of Americans and rejected a government-run health care system.
Moreover, he affirmed that transparency in health care will continue to bring overall costs down. In 2019, the Trump administration passed legislation requiring enhanced transparency for the cost of care, which will go into effect in 2021. This transparency will help families save “money for substantially better care.”
Finally, and similar to the 2019 SOTU, President Trump announced that the administration will “always protect patients with pre-existing conditions,” which has been a key concern for the past few years.
Public pressure continues to mount over the issue of paid family leave, and states are proposing and passing their own versions of this type of leave. In the SOTU, President Trump referenced and called upon Congress to pass the bipartisan Advancing Support for Working Families Act, a law that would provide new parents within the federal workforce paid family leave. He stated that this law, if passed, would serve as a model for the rest of the country to extend paid leave to parents across the nation.
Lowering prescription drug costs has been a focus of the Trump administration. In past years, steps have been taken to increase transparency of prescription drug costs and potentially increase consumer savings. In the SOTU, President Trump announced that 2019 was the first year in 51 years that the cost of prescription drugs decreased. He also called upon Congress to produce bipartisan legislation that would “dramatically [lower] prescription drug prices.”
Historically, the SOTU is meant to be uplifting and is designed to serve as an olive branch to bring a divided Congress together. It’s important to remember that it’s just a speech, and what actions will come out of it will remain to be seen.
The issues discussed above are just a few of the issues the president addressed in his SOTU. We will continue to monitor any developments on issues and provide updates as necessary. For more information on Federal Paid Family Leave and Prescription Drug Cost Reform contact LoVasco Consulting Group today.
This article is for educational purposes only. The tax and legal references attached herein are designed to provide accurate and authoritative information with regard to the subject matter covered and are provided with the understanding that LoVasco Consulting Group is not engaged in rendering tax or legal services. If tax or legal advice is required, you should consult your accountant or attorney. LoVasco Consulting Group does not replace those advisors.
Securities and Investment Advisory Services offered through M Holdings Securities, Inc., a registered broker dealer and Investment Advisor, member FINRA / SIPC. LoVasco Consulting Group is independently owned and operated.
Return to Insights Page
LoVasco Consulting Group and their agents are presently licensed to sell traditional life insurance in Michigan as a resident producer and numerous other states as a nonresident producer. This site is not intended as an offer to sell securities, which may be done only after proper delivery of a prospectus and a client suitability review. Proper state registration is mandatory prior to conducting business in any state. Securities and Investment Advisory Services offered through M Holdings Securities, Inc., a registered broker dealer and Investment Advisor, member FINRA / SIPC. Check the background of this Firm and/or investment professional on FINRA's BrokerCheck. LoVasco Consulting Group is owned and operated independently from M Holdings Securities, Inc. LoVasco Consulting Group is a member of M Financial Group. Please click here for further details regarding this relationship.